Veradermics, Incorporated
138.78USD
+0.2900 (+0.21%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on MANE.
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| Operating Income | -30 | -30 | -16 | -13 |
| Net Income | -24 | -27 | -16 | -12 |
| EPS (Diluted) | -$0.58 | -$1.32 | -$24.19 | -$19.79 |
Source: SEC filings (EDGAR)